HOME >> BIOLOGY >> NEWS
Architectural plan revealed of doomsday arctic seed vault

OSLO, NORWAY (9 February 2007)The Norwegian government has revealed the architectural design for the Svalbard International Seed Vault, to be carved deep into frozen rock on an island not far from the North Pole. The entrance to the "fail-safe" seed vault will "gleam like a gem in the midnight sun," signaling a priceless treasure within: seed samples of nearly every food crop of every country. The vault is designed to protect the agricultural heritage of humankindthe seeds essential to agriculture of every nation.

"This design takes us one step closer to guaranteeing the safety of the world's most important natural resource," said Dr. Cary Fowler, Executive Director of the Global Crop Diversity Trust, which will co-fund the vault's operations and pay for the preparation and transport of seeds from all developing nations to the Arctic island of Svalbard. "Every day that passes we lose crop biodiversity. We must conserve the seeds that will allow agriculture to adapt to challenges such as climate change and crop disease. This design is as awesome physically as it is attractive aesthetically, and both are fitting tributes to the importance of the biological treasure to be stored there."

Construction is slated to begin in March 2007 and to be completed in September 2007. The vault will officially open in late winter 2008.

"By investing in a global permafrost safety facility for seeds, the Norwegian Government hopes to contribute to combating the loss of biological diversity, to reduce our vulnerability to climatic changes, and to enhance our ability to secure future food production," said Mr. Terje Riis-Johansen, Minister of Agriculture and Food, Norway.

The site was chosen, in part, because the ground is perpetually frozen, providing natural back-up refrigeration that would preserve the seeds should electricity fail. Yet, even here, project architects had to consider how to offset the potential impacts of climate c
'"/>

Contact: Jeff Haskins
jhaskins@burnesscommunications.com
301-652-1558
Burness Communications
8-Feb-2007


Page: 1 2 3

Related biology news :

1. Universes stringy birth revealed by young Czech scientist in EURYI winning project
2. Discredited Korean embryonic stem cells true origins revealed
3. Toxoplasmosis infection trick revealed by scientists
4. Genetic roots of bipolar disorder revealed by first genome-wide study of illness
5. Quantum secrets of photosynthesis revealed
6. New bird, bat species revealed by extensive DNA barcode studies
7. Humans ecological footprint in 2015 and Amazonia revealed
8. Secrets revealed in sequencing of honey bee genome
9. Novel biomarker for prediction of survival in colorectal carcinomas revealed
10. Cells fight against cancer revealed
11. Genetic clues to cardiomyopathys origins revealed in mice

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Architectural plan revealed doomsday arctic seed vault

(Date:5/21/2013)... Illinois at Chicago College of Medicine will study gender differences ... main energy source -- and how changes in fat metabolism ... million, 4-year grant from the National Heart, Lung and Blood ... fuel for energy. These changes may play a major role ... men and women, says E. Douglas Lewandowski, director of the ...
(Date:5/21/2013)... few decades, scientists have developed many devices that can ... While generally effective, each of these treatments has drawbacks, ... study from MIT analyzes the potential usefulness of a ... and drug-releasing stents, but may pose fewer risks. With ... artery for only a brief period, during which it ...
(Date:5/21/2013)... 2013 Royal Philips Electronics (NYSE: PHG, AEX: ... portable ultrasound with Philips, industry leading Live 3D TEE, ... xMATRIX with available Live 3D TEE and ICE will ... the EuroPCR, official meeting for the European Association of ... its launch in 2012, Philips CX50 xMATRIX has been ...
Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
(Date:5/21/2013)... -- First patients dosed with PSX1002, an ... using Prosonix, particle engineering platform Prosonix, an ... Respiratory Medicines by Design , has initiated a ... its effect on lung function and the safety of ... severe chronic obstructive pulmonary disease (COPD). The first two ...
(Date:5/21/2013)... by George Washington University Professor Tianshu Li provide ... small droplets is strongly size-dependent, an important conclusion ... formation of ice at the nanoscale is a ... has important implications for climate research and other ... supercooled water is generally initiated by a process ...
(Date:5/21/2013)... Smarter Security, Inc., provider of premium, innovative ... Genzyme, a Sanofi company and leading biotech company, recently ... a multi-use facility in the United States. With Door ... this latest order underscores the satisfaction and success the ... device improving doorway access control. , “We recommend ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. today ... of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody ... the HER2 oncoprotein," will be presented at the ... Clinical Oncology during the Developmental Therapeutics - Immunotherapy ... 4:15 – 4:30 PM.  The presentation will describe ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: